Publication: Autonomic dysfunction in people with neuromyelitis optica spectrum disorders
dc.contributor.author | Crnošija, Luka (55943212800) | |
dc.contributor.author | Krbot Skorić, Magdalena (55915654300) | |
dc.contributor.author | Andabaka, Marko (57207949404) | |
dc.contributor.author | Junaković, Anamari (55252791400) | |
dc.contributor.author | Martinović, Vanja (56925159700) | |
dc.contributor.author | Ivanović, Jovana (57196371316) | |
dc.contributor.author | Mesaroš, Šarlota (7004307592) | |
dc.contributor.author | Pekmezović, Tatjana (7003989932) | |
dc.contributor.author | Drulović, Jelena (55886929900) | |
dc.contributor.author | Habek, Mario (14050219000) | |
dc.date.accessioned | 2025-06-12T14:19:50Z | |
dc.date.available | 2025-06-12T14:19:50Z | |
dc.date.issued | 2020 | |
dc.description.abstract | Aims: To determine the difference in autonomic symptom burden measured with the Composite Autonomic System Score-31 (COMPASS-31) and presence of objective dysautonomia in people with neuromyelitis optica spectrum disorders (pwNMOSD) compared to people with multiple sclerosis (pwMS). Design/Methods: Twenty pwNMOSD and 20 pwMS, matched for age, sex, and disease duration, were enrolled. All patients completed the COMPASS-31. The quantification of cardiovascular autonomic dysfunction (CAD) was made using the two indices of the Composite Autonomic Scoring Scale (CASS): adrenergic index (AI) and cardiovagal index (CI). Results: In all pwNMOSD, COMPASS-31 was >0. Sympathetic dysfunction was present in 8 (40%), parasympathetic dysfunction in 10 (50%), and orthostatic hypotension in 6 (30%) pwNMOSD. This group of patients had higher frequency and level on the pupillomotor domain of the COMPASS-31 compared to pwMS (p = 0.048 and p = 0.006, respectively). A binary logistic regression model showed that drop in diastolic blood pressure (dBP) during tilt-table test and normal function of autonomic nervous system, defined as AI = 0 and CI = 0, were independent predictors of pwNMOSD (p = 0.042 and p = 0.029, respectively). If CAD was present, it was significantly worse in pwNMOSD compared to pwMS (p = 0.003). Conclusion: Significant proportion of pwNMOSD experience dysautonomia, which seems to be different from dysautonomia observed in pwMS. © The Author(s), 2019. | |
dc.identifier.uri | https://doi.org/10.1177/1352458519837703 | |
dc.identifier.uri | https://www.scopus.com/inward/record.uri?eid=2-s2.0-85063347775&doi=10.1177%2f1352458519837703&partnerID=40&md5=862e1a8696148085d6ddabdad9da1434 | |
dc.identifier.uri | https://remedy.med.bg.ac.rs/handle/123456789/4864 | |
dc.subject | autonomic dysfunction | |
dc.subject | multiple sclerosis | |
dc.subject | Neuromyelitis optica spectrum disorders | |
dc.title | Autonomic dysfunction in people with neuromyelitis optica spectrum disorders | |
dspace.entity.type | Publication |